Post-Sternotomy Pain


  • Pain after median sternotomy can be difficult to treat, and poorly controlled is associated with complications:
Sequelae of poor pain control after sternotomy
Post-operative pulmonary complications
Arrhythmias
MI or other cardiac complications
Impaired wound healing
Prolonged length of stay
Chronic post-sternotomy pain syndrome (a form of CPSP)

  • Post-operative massage improves short-term pain scores although objective outcome measures often not reported
  • Music therapy reduces pain scores without reducing opioid consumption
  • Patient education does not improve opioid consumption or pain scores whether performed pre- or post-operatively

Paracetamol

  • Use associated with improvement pain scores ± reduction in opioid consumption vs. placebo
  • Should be regularly used in the pre-, intra- and post-operative periods

NSAIDs

  • NSAIDs are recommended for pre- or intra-operative use, where not contraindicated, in combination with paracetamol
  • Evidence suggests low risk of AKI, cardiac adverse events or significant bleeding with short duration of use
  • In our CICU, 100mg rectal diclofenac is administered prior to extubation
  • COX-2 specific inhibitors are not recommended by PROSPECT guidance

Opioids

  • No evidence to support use of one opioid over any other
  • Should generally be reserved as rescue analgesia post-operatively
  • In our CICU, regular dihydrocodeine is often used alongside PRN immediate release enteral opioid

NMDA antagonists

  • Magnesium use is associated with reduced pain scores and opioid requirements
  • Optimal dosing unclear; one study used 2g bolus followed by 2g/day

  • No difference in pain score or opioid use from two studies where ketamine was used intraoperatively
  • On this basis, not recommended by PROSPECT guidance

Dexmedetomidine

  • Intra- or post-operative infusions may improve outcomes, reduce pain scores and opioid requirements
  • Has negative cardiovascular effects (hypotension, bradycardia), which may preclude its use
  • Optimal dosing unknown; one study infused 0.5 μg kg−1 h−1 from initiation of anaesthesia until tracheal extubation in ICU

Gabapentinoids

  • Should be resumed in patients who are on the drugs long-term
  • Not associated with shorter duration of extubation or length of ICU stay in two trials of pregabalin vs. placebo in cardiac surgery
  • Quality of evidence of routine use after cardiac surgery is low; not recommended by PROSPCET guidance due to 'inconsistent procedure-specific evidence'

Others

  • Lidocaine patches; often used for pain arising from chest drain sites or severe post-operative sternotomy pain, but not robustly evidence based
  • Nefopam; may be used to reduce opioid consumption and opioid-related side effects, but not always available, itself has limiting side-effects and lacks robust evidence
  • Entonox; sometimes used for chest drain or cardiac pacing wire removal, but not recommended by PADIS guidelines due to low quality evidence


Block Advantages Disadvantages
Surgical site LA infusion ↓ pain score
↓ opioid consumption
Parasternal block ↓ pain score
↓ opioid consumption
Safe in anticoagulated patient
Paravertebral block Analgesia no better than TEA
Debatable effect on pain score and opioid use
Transversus thoracis plane block ↓ pain score No ↓ opioid consumption
May be inappropriate if LIMA grafted
Erector spinae block ↓ pain score
↓ opioid consumption
Non-inferior to TEA
Limited evidence in cardiac surgery
Thoracic epidural
Intrathecal opioids
↓ pain score
↓ opioid consumption
Standard risks of neuraxial intervention
Meta-analyses don't show clear analgesic benefit
No significant ↓ in POPC
Safety concerns in anticoagulated patients
Lidocaine infusions No improvement in pain or organisational outcomes
Lack of procedure-specific evidence